NEUTROPHIL DYSPLASIA CAUSED BY MYCOPHENOLATE MOFETIL
Authors:
- Ozay HalilOHOzay Halil
- Barbara J. BainBBBarbara J. Bain
- David CumminsDCDavid Cummins
- Nicholas R. BannerNBNicholas R. Banner
- 1 December 2000
- journal article
- case report
- Published by Wolters Kluwer Health in Transplantation
- Vol. 70 (11) , 1608-1610
Abstract
Two transplant recipients developed striking morphological abnormalities in their circulating neutrophils while receiving mycophenolate. The changes included nuclear hypolobulation and abnormal clumping of nuclear chromatin and were presumably related to inhibition of guanosine nucleoside synthesis. In both cases the neutrophil abnormalities preceded the development of neutropenia and were thus a sign of impending hematological toxicity. The hematological changes resolved after the drug was discontinued.Keywords
This publication has 8 references indexed in Scilit:
- MYCOPHENOLATE MOFETIL IN RENAL TRANSPLANTATION: 3-YEAR RESULTS FROM THE PLACEBO-CONTROLLED TRIAL1Transplantation, 1999
- Combination therapy with tacrolimus and mycophenolate mofetil following cardiac transplantation: importance of mycophenolic acid therapeutic drug monitoringThe Journal of Heart and Lung Transplantation, 1999
- A RANDOMIZED ACTIVE-CONTROLLED TRIAL OF MYCOPHENOLATE MOFETIL IN HEART TRANSPLANT RECIPIENTS1Transplantation, 1998
- Relation of Mycophenolic Acid Trough Levels and Adverse Events in Kidney Allograft RecipientsTransplantation Proceedings, 1998
- DECREASED PROTEIN BINDING OF MYCOPHENOLIC ACID ASSOCIATED WITH LEUKOPENIA IN A PANCREAS TRANSPLANT RECIPIENT WITH RENAL FAILURETransplantation, 1998
- Pharmacokinetics of Mycophenolic Acid in Renal Transplant Patients with Delayed Graft FunctionThe Journal of Clinical Pharmacology, 1998
- Purine metabolism and immunosuppressive effects of mycophenolate mofetil (MMF)Clinical Transplantation, 1996
- Mycophenolic Acid: Measurement and Relationship to Pharmacologie EffectsTherapeutic Drug Monitoring, 1995